We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
-3.24%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$73.5B
AUM Growth
-$7.73B
(-9.5%)
Cap. Flow
-$10.4B
Cap. Flow
% of AUM
-14.12%
Top 10 Holdings %
Top 10 Hldgs %
24.14%
Holding
2,549
New
227
Increased
861
Reduced
712
Closed
243
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$301M |
| 2 |
Estee Lauder
EL
|
+$252M |
| 3 |
Boeing
BA
|
+$251M |
| 4 |
Kenvue
KVUE
|
+$174M |
| 5 |
Fidelity National Information Services
FIS
|
+$166M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$547M |
| 2 |
Union Pacific
UNP
|
+$459M |
| 3 |
Pinnacle West Capital
PNW
|
+$203M |
| 4 |
Wells Fargo
WFC
|
+$199M |
| 5 |
Bank of America
BAC
|
+$199M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.75% |
| 2 | Healthcare | 13.74% |
| 3 | Financials | 13.36% |
| 4 | Industrials | 11.58% |
| 5 | Consumer Discretionary | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Voyager Therapeutics
VYGR
$198M
| $178K | ﹤0.01% |
23,025
+899
| +4% | +$8.21K |
|
1227
Apple Hospitality REIT
APLE
$3.82B
| $177K | ﹤0.01% |
11,569
| – | – |
|
1228
Concentrix
CNXC
$1.57B
| $177K | ﹤0.01% |
2,215
-29,646
| -93% | -$2.33M |
|
1229
Mesa Laboratories
MLAB
$574M
| $177K | ﹤0.01% |
+1,685
| New | +$216K |
|
|
DRD
1230
DRDGold
DRD
$2.05B
| $176K | ﹤0.01% |
21,296
+20,300
| +2,038% | +$205K |
|
1231
iShares S&P 500 Value ETF
IVE
$49.8B
| $176K | ﹤0.01% |
1,150
| – | – |
|
1232
Molson Coors Class B
TAP
$8.1B
| $176K | ﹤0.01% |
2,768
+2,464
| +811% | +$160K |
|
1233
ANI Pharmaceuticals
ANIP
$1.78B
| $175K | ﹤0.01% |
3,022
+495
| +20% | +$28.6K |
|
1234
Power Integrations
POWI
$3.6B
| $175K | ﹤0.01% |
2,305
+1,090
| +90% | +$93.3K |
|
1235
Dole
DOLE
$1.32B
| $173K | ﹤0.01% |
15,004
+8,424
| +128% | +$105K |
|
|
GRSD
1236
Grandstand Limited Ordinary Shares
GRSD
$67M
| $173K | ﹤0.01% |
13,274
+3,235
| +32% | +$41K |
|
|
IAS
1237
DELISTED
Integral Ad Science
IAS
| $173K | ﹤0.01% |
14,641
+1,485
| +11% | +$23K |
|
1238
Universal Logistics Holdings
ULH
$529M
| $172K | ﹤0.01% |
6,835
+3,696
| +118% | +$106K |
|
1239
Genie Energy
GNE
$384M
| $171K | ﹤0.01% |
11,651
-9,187
| -44% | -$133K |
|
1240
Lear
LEA
$8.18B
| $171K | ﹤0.01% |
1,282
+699
| +120% | +$101K |
|
|
MMT
1241
Aberdeen Multi-Market Income Fund
MMT
$243M
| – | – |
0
| – | – |
|
1242
Calix
CALX
$2.39B
| $170K | ﹤0.01% |
3,735
-5,344
| -59% | -$242K |
|
1243
Markel Group
MKL
$23.2B
| $169K | ﹤0.01% |
115
| – | – |
|
1244
Radiant Logistics
RLGT
$395M
| $169K | ﹤0.01% |
30,014
+3,200
| +12% | +$21.7K |
|
1245
S&T Bancorp
STBA
$1.79B
| $169K | ﹤0.01% |
6,272
+2,668
| +74% | +$77.1K |
|
1246
Organon & Co
OGN
$3.57B
| $168K | ﹤0.01% |
9,706
-44
| -0.5% | -$917 |
|
|
PGRE
1247
DELISTED
Paramount Group
PGRE
| $168K | ﹤0.01% |
36,377
-3,075
| -8% | -$15.2K |
|
1248
Consolidated Water Co
CWCO
$488M
| $167K | ﹤0.01% |
5,873
+430
| +8% | +$10.6K |
|
|
AAN
1249
DELISTED
The Aaron's Company Inc
AAN
| $167K | ﹤0.01% |
16,077
+10,193
| +173% | +$130K |
|
1250
Open Text
OTEX
$6.04B
| $166K | ﹤0.01% |
4,735
+2,306
| +95% | +$90.3K |
|
Similar funds
QCM
Lazard Asset Management's Q3 2023 Portfolio in Review
As of Q3 2023, Lazard Asset Management held 2,549 positions worth $73.5B, down 9.5% from $81.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Lazard Asset Management withdrew a net $10.4B in Q3 2023, closing 243 positions and reducing 712 holdings. Its most notable exit was Littelfuse, an estimated $24.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in ScottsMiracle-Gro worth $28.3M.
- Lazard Asset Management's largest Q3 2023 buy was ScottsMiracle-Gro: 548,310 shares worth $28.3M.
- Lazard Asset Management added most to PPL Corp in Q3 2023, an estimated $301M increase.
- Lazard Asset Management's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $547M.
- Lazard Asset Management fully exited Littelfuse in Q3 2023, selling an estimated $24.3M.
- Lazard Asset Management's ten largest holdings make up 24% of its $73.5B portfolio in Q3 2023.
- Lazard Asset Management opened 227 new positions and closed 243 in Q3 2023.
- Lazard Asset Management's portfolio value fell 9.5% quarter-over-quarter to $73.5B.
Based on Lazard Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.